REGENXBIO Inc.
Price Action
Technical Summary
WEAKENINGREGENXBIO Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 58), indicating performance broadly in line with the market. Earnings contraction of 15% provides fundamental context to the price action. However, price is extended 30% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $7.56 | +38.56% | ABOVE |
| 50 SMA | $8.04 | +30.41% | ABOVE |
| 100 SMA | $8.42 | +24.40% | ABOVE |
| 150 SMA | $10.11 | +3.62% | ABOVE |
| 200 SMA | $10.35 | +1.30% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is RGNX in an uptrend right now?
RGNX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is RGNX overbought or oversold?
RGNX's RSI (14) is 72. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is RGNX outperforming the market?
RGNX has a Relative Strength (RS) Rating of 58 out of 99. RGNX is performing about average compared to the market.
Where is RGNX in its 52-week range?
RGNX is trading at $10.48, which is 65% of its 52-week high ($16.19) and 47% above its 52-week low ($5.46).
How volatile is RGNX?
RGNX has a Beta of 2.03 and 52-week volatility of 87%. It's more volatile than the S&P 500 - expect bigger swings.